Moneycontrol PRO
HomeNewsBusinessMarkets$11 trillion and counting: Global stock slump may not be over

$11 trillion and counting: Global stock slump may not be over

Historically significant technical levels for the S&P 500 show the index has room to fall nearly 14% more before hitting key support levels, while the share of companies that have so far hit a one-year low is still a far cry from the number during the economic growth scare that slammed stocks in 2018.

May 15, 2022 / 20:58 IST
Representative image

A mass exodus of money, an $11 trillion wipeout, and the worst losing streak for global stocks since the 2008 financial crisis. The bad news is that it may not be over yet.

The selloff in the MSCI ACWI Index has dramatically lowered valuations of companies across the US and Europe, but strategists ranging from Michael Wilson at Morgan Stanley to Robert Buckland at Citigroup Inc. expect stocks to fall further amid worries of high inflation, hawkish central banks and slowing economic growth, especially in the US.

Money is continuing to leave every asset class and the exodus is deepening as investors rush out of names like Apple Inc., according to Bank of America Corp. Historically significant technical levels for the S&P 500 show the index has room to fall nearly 14% more before hitting key support levels, while the share of companies that have so far hit a one-year low is still a far cry from the number during the economic growth scare that slammed stocks in 2018.

ALSO READ: Explained | Why the US stock market is tumbling in 2022

“Investors continue to reduce their positions, particularly in technology and growth stocks,” said Andreas Lipkow, a strategist at Comdirect Bank. “But sentiment needs to deteriorate significantly more to form a potential floor.”

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

On the other side, some say the rout has already created pockets of value across sectors including commodities and even technology, which is valued on future earnings growth and, therefore, generally shunned during periods of high interest rates. The Nasdaq 100 rallied on Friday, but it still closed the week down over 2%.

Goldman Sachs Group Inc.’s Peter Oppenheimer has been among the most high-profile strategists to say it’s time to buy the dip, while Thomas Hayes, chairman at Great Hill Capital LLC, said “old school tech” stocks including Intel Corp and Cisco Systems Inc. were now trading at attractive multiples.

But amid the morsels of value, the broader market looks to be buckling as recession creeps more and more into the conversation. And even as growth worries mount, the inflation focus at the Federal Reserve and other central banks means investors can’t count any more on the monetary elixir that’s helped to keep alive the long-running bull market.

The MSCI ACWI has fallen for six straight weeks, the Stoxx Europe 600 is down 6% since late March, while the S&P 500 has dropped more than twice as much.

Here are some key metrics showing the potential downside for stock markets.

Falling Fast

The S&P 500 is still about 14% above its 200-week moving average, a level that’s previously been a floor during all major bear markets, except for the tech bubble and the global financial crisis. Strategists at Canaccord Genuity say there could be further declines on Monday on forced margin selling after yet another red week for the US benchmark.

Stressing Out

For all the recent declines -- the S&P 500 is down more than 13% from its high on March 29 -- stress indicators also aren’t at levels seen during comparable slumps. Fewer than 30% of the benchmark’s members have hit a one-year low, compared with nearly 50% during the growth scare in 2018 and 82% during the global financial crisis in 2008.

In addition, the 14-day relative strength index suggests the S&P 500 isn’t yet at the floor. While the Stoxx Europe 600 Index entered into oversold territory last week, the US benchmark has not yet hit that level, which is generally a precursor to a rebound.

Getting Defensive

Defensive stocks have been in demand as the specter of slowing growth hammers economically sensitive cyclical sectors. The Stoxx 600 Defensives Index is flat in 2022 versus a 15% drop for cyclicals, and strategists at Barclays and Morgan Stanley expect that trend to continue. At UBS Wealth Management, Claudia Panseri sees pricing for a “mild recession” in the cyclical-versus-defensive relative performance.

Comparison with past periods of defensive strength also signals the potential for more to come. Relative gains this year still trail the performance in 2016, brought on by a slowdown in China and Brexit worries, and in the early days of the pandemic in 2020.

Cheap-ish

Although valuations of technology stocks have fallen sharply -- the tech-heavy Nasdaq 100 now trades at about 20-times forward earnings, the lowest since April 2020 -- some strategists expect them to remain under pressure from aggressive monetary tightening by central banks.

Tech stocks just suffered their biggest weekly outflows of the year, according to Bank of America. And even after the crushing price drops, Valerie Gastaldy, a technical analyst at Day By Day SAS, says the sector is at risk of losing another 10% before finding a floor.

“I don’t think we have seen capitulation just yet,” said Dan Boardman-Weston, chief executive of BRI Wealth Management. “This week has been pretty brutal, and investor sentiment, especially in the technology area, is shot to pieces. We’re going to have a tricky few weeks and months ahead.”

Bloomberg
first published: May 15, 2022 08:58 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
CloseOutskill Genai